Phase II-I-II study of two different doses and schedules of pralatrexate, a high-affinity substrate for the reduced folate carrier, in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies
| Image |  |
|---|---|
| Description | scientific article published on 3 August 2009 |
| Author/s |
author: Owen A. O'Connor Andrew D Zelenetz Debra M Sarasohn Paul Hamlin Steven M Horwitz |
| Publication date | August 3, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |